This is a regulatory disclosure submitted by Natco Pharma Limited to the BSE Limited and the National Stock Exchange of India Ltd.
The purpose of the communication is to inform the exchanges that the company will host an earnings call with investors and analysts. The call is scheduled for Friday, 13th November 2026 at 16:00 hours IST. The objective of the call is to discuss the company's unaudited financial results for the quarter ended 30th September 2026.
Interested participants are required to pre-register for the Zoom call by clicking on a provided hyperlink. The letter advises participants to join 5 minutes prior to the call.
The document was digitally signed by Venkat Ramesh Chekuri on 6th November 2026 at 16:16:36 IST. The signatory is identified as Ch. Venkat Ramesh, holding the position of Company Secretary & Compliance Officer for Natco Pharma Limited.
The communication is marked as being for the information and records of the exchanges.